Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | ARMISTICE CAPITAL LLC | 6 9.990% | 6 (New Position) | Filing History |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 987,211 9.990% | 987,211 (New Position) | Filing History |
| 2023-02-14 12:22 pm Purchase | 2022-12-31 | 13G | ContraFect Corporation CFRX | ARMISTICE CAPITAL LLC | 60,358 9.990% | 60,358 (New Position) | Filing History |
| 2023-02-14 12:20 pm Purchase | 2022-12-31 | 13G | Conformis, Inc. CFMS | ARMISTICE CAPITAL LLC | 480,000 6.000% | 480,000 (New Position) | Filing History |
| 2023-02-14 12:19 pm Purchase | 2022-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ | ARMISTICE CAPITAL LLC | 2,666,666 6.750% | 2,666,666 (New Position) | Filing History |
| 2023-02-14 12:18 pm Purchase | 2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ | ARMISTICE CAPITAL LLC | 1,165,709 4.990% | 1,165,709 (New Position) | Filing History |
| 2023-02-14 12:16 pm Sale | 2022-12-31 | 13G | Bit Digital, Inc. BTBT | ARMISTICE CAPITAL LLC | 3,161,889 3.690% | -1,053,963 (-25.00%) | Filing History |
| 2023-02-14 12:15 pm Purchase | 2022-12-31 | 13G | Bruush Oral Care Inc. BRSH | ARMISTICE CAPITAL LLC | 44,917 9.990% | 44,917 (New Position) | Filing History |
| 2023-02-14 12:06 pm Purchase | 2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | ARMISTICE CAPITAL LLC | 955,995 9.990% | 23,943 (+2.57%) | Filing History |
| 2023-02-14 12:05 pm Purchase | 2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR | ARMISTICE CAPITAL LLC | 1,298,965 5.700% | 1,298,965 (New Position) | Filing History |
| 2023-02-14 12:03 pm Purchase | 2022-12-31 | 13G | Avinger, Inc. AVGR | ARMISTICE CAPITAL LLC | 52,627 9.990% | 52,627 (New Position) | Filing History |
| 2023-02-14 12:02 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | ARMISTICE CAPITAL LLC | 10,224,000 5.910% | 10,224,000 (New Position) | Filing History |
| 2023-02-14 12:00 pm Purchase | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | ARMISTICE CAPITAL LLC | 2,997,111 9.990% | 2,997,111 (New Position) | Filing History |
| 2023-02-14 11:59 am Purchase | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | ARMISTICE CAPITAL LLC | 2,997,111 9.990% | 2,997,111 (New Position) | Filing History |
| 2023-02-14 11:58 am Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | ARMISTICE CAPITAL LLC | 5,333,951 9.990% | 5,333,951 (New Position) | Filing History |
| 2023-02-14 11:54 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | ARMISTICE CAPITAL LLC | 2,750,000 5.010% | 2,750,000 (New Position) | Filing History |
| 2023-02-14 11:53 am Purchase | 2022-12-31 | 13G | Addex Therapeutics Ltd ADXN | ARMISTICE CAPITAL LLC | 201,923 4.970% | 170,283 (+538.19%) | Filing History |
| 2023-02-14 11:52 am Purchase | 2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP | ARMISTICE CAPITAL LLC | 880,000 7.590% | 880,000 (New Position) | Filing History |
| 2023-02-14 11:50 am Purchase | 2022-12-31 | 13G | Talphera, Inc. TLPH | ARMISTICE CAPITAL LLC | 864,328 9.990% | 864,328 (New Position) | Filing History |
| 2023-02-14 11:49 am Purchase | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | ARMISTICE CAPITAL LLC | 1,106,000 6.440% | 1,106,000 (New Position) | Filing History |